Matteo Montagner1, Markus Kofler1, Roland Heck1, Semih Buz1,2, Christoph Starck1,2, Stephan Kurz1,3, Volkmar Falk1,2,3,4, Jörg Kempfert1,2. 1. Department of Cardiothoracic and Vascular Surgery, German Heart Center, Berlin, Germany. 2. DZHK (German Centre for Cardiovascular Research), Partner Site, Berlin, Germany. 3. Department of Cardiovascular Surgery, Charité-Berlin Medical School, Berlin, Germany. 4. Department of Health Sciences and Technology, Translational Cardiovascular Technologies, Institute of Translational Medicine, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland.
Abstract
OBJECTIVES: The goal of the present study is to investigate changes in supra-aortic vessel perfusion after implantation of the non-covered Ascyrus Medical Dissection Stent (AMDS) for surgical treatment of acute type A aortic dissection. METHODS: From 2017 to 2020, 16 consecutive patients treated with AMDS and involvement (dissection to total occlusion) of at least 1 supra-aortic vessel were included in the study. Centre-line based computed tomography measurements of true, false and total lumen area using Terarecon software were performed before and after surgery. Changes in the true lumen area were indexed to the entire vessel area. The paired sample t-test was used to assess the significance of the observed differences. RESULTS: Analysis of supra-aortic vessels and the descending aorta showed significant improvement in true lumen perfusion after the AMDS was implanted. The indexed true lumen area increased postoperatively by 72%, 112% and 30% in the innominate, right and left common carotid arteries, respectively. Total occlusions of both common carotid arteries recovered completely after surgical treatment. The proximal- and the mid-descending aorta showed a 78% and 48% improvement of the indexed true lumen area, respectively. CONCLUSIONS: Arch repair using AMDS shows promising results in the treatment of acute type A aortic dissection. Quantitative measurements of true and false lumen perfusion demonstrated a significant increase in true lumen area and a 100% regression of totally occluded supra-aortic branches. Further examination in a larger cohort of patients and comparison with isolated hemiarch repair are needed to confirm positive vascular remodelling after an AMDS implant.
OBJECTIVES: The goal of the present study is to investigate changes in supra-aortic vessel perfusion after implantation of the non-covered Ascyrus Medical Dissection Stent (AMDS) for surgical treatment of acute type A aortic dissection. METHODS: From 2017 to 2020, 16 consecutive patients treated with AMDS and involvement (dissection to total occlusion) of at least 1 supra-aortic vessel were included in the study. Centre-line based computed tomography measurements of true, false and total lumen area using Terarecon software were performed before and after surgery. Changes in the true lumen area were indexed to the entire vessel area. The paired sample t-test was used to assess the significance of the observed differences. RESULTS: Analysis of supra-aortic vessels and the descending aorta showed significant improvement in true lumen perfusion after the AMDS was implanted. The indexed true lumen area increased postoperatively by 72%, 112% and 30% in the innominate, right and left common carotid arteries, respectively. Total occlusions of both common carotid arteries recovered completely after surgical treatment. The proximal- and the mid-descending aorta showed a 78% and 48% improvement of the indexed true lumen area, respectively. CONCLUSIONS: Arch repair using AMDS shows promising results in the treatment of acute type A aortic dissection. Quantitative measurements of true and false lumen perfusion demonstrated a significant increase in true lumen area and a 100% regression of totally occluded supra-aortic branches. Further examination in a larger cohort of patients and comparison with isolated hemiarch repair are needed to confirm positive vascular remodelling after an AMDS implant.
Authors: Maximilian Luehr; Christian D Etz; Michal Nozdrzykowski; Lukas Lehmkuhl; Martin Misfeld; Farhad Bakhtiary; Michael A Borger; Friedrich-Wilhelm Mohr Journal: Eur J Cardiothorac Surg Date: 2015-02-26 Impact factor: 4.191
Authors: Martin Czerny; Florian Schoenhoff; Christian Etz; Lars Englberger; Nawid Khaladj; Andreas Zierer; Ernst Weigang; Isabell Hoffmann; Maria Blettner; Thierry P Carrel Journal: J Am Coll Cardiol Date: 2015-06-23 Impact factor: 24.094
Authors: Sabin J Bozso; Jeevan Nagendran; Michael W A Chu; Bob Kiaii; Ismail El-Hamamsy; Maral Ouzounian; Jörg Kempfert; Christoph Starck; Ali Shahriari; Michael C Moon Journal: Ann Thorac Surg Date: 2019-06-27 Impact factor: 4.330
Authors: Bartosz Rylski; Paul P Urbanski; Matthias Siepe; Friedhelm Beyersdorf; Jean Bachet; Thomas G Gleason; Joseph E Bavaria Journal: Eur J Cardiothorac Surg Date: 2014-08 Impact factor: 4.191
Authors: Marco Di Eusanio; Himanshu J Patel; Christoph A Nienaber; Daniel M Montgomery; Amit Korach; Thoralf M Sundt; Carlo Devincentiis; Matthias Voehringer; Mark D Peterson; Truls Myrmel; Gianluca Folesani; Magnus Larsen; Nimesh D Desai; Joseph E Bavaria; Jehangir J Appoo; Teresa M Kieser; Rossella Fattori; Kim Eagle; Roberto Di Bartolomeo; Santi Trimarchi Journal: J Thorac Cardiovasc Surg Date: 2013-03 Impact factor: 5.209
Authors: Julia Dumfarth; Markus Kofler; Lukas Stastny; Simone Gasser; Michaela Plaikner; Severin Semsroth; Christoph Krapf; Thomas Schachner; Nikolaos Bonaros; Michael Grimm Journal: Ann Thorac Surg Date: 2020-02-28 Impact factor: 4.330
Authors: John G T Augoustides; Arnar Geirsson; Wilson Y Szeto; Elizabeth K Walsh; Brittany Cornelius; Alberto Pochettino; Joseph E Bavaria Journal: Nat Clin Pract Cardiovasc Med Date: 2008-12-09
Authors: Arash Mehdiani; Yukiharu Sugimura; Louise Wollgarten; Moritz Benjamin Immohr; Sebastian Bauer; Hubert Schelzig; Markus Udo Wagenhäuser; Gerald Antoch; Artur Lichtenberg; Payam Akhyari Journal: Front Cardiovasc Med Date: 2022-07-14